Search

Displaying results 5471 - 5480 of 9670 in total
  1. Drug

    Denifanstat

    go.drugbank.com/drugs/DB17576
    Investigational

    Due to its antineoplastic activities, it is being investigated for various cancers.

  2. Drug

    LY-517717

    go.drugbank.com/drugs/DB05713
    Investigational

    It is believed to be Lilly's PMD-3112 (licensed from Amgen).

  3. Drug

    Betacetylmethadol

    go.drugbank.com/drugs/DB01522
    ExperimentalIllicit

    It is used mainly in the treatment of narcotic dependence. [PubChem]

  4. Drug

    Prifinium

    go.drugbank.com/drugs/DB13254
    Experimental

    It may be useful for the treatment of irritable bowel syndrome [A175027].

  5. Drug

    OPC-51803

    go.drugbank.com/drugs/DB05838
    Experimental

    It is useful therapeutic drug in the treatment of hypothalamic diabetes insipidus, nocturnal enuresis, and some kinds of urinary incontinence. … It is a V(2)-selective agonist that produces a significant antidiuretic action after single and multiple oral dosing in AVP-deficient and normal AVP states.

  6. Drug

    Vevorisertib

    go.drugbank.com/drugs/DB21481
    Investigational

    Vevorisertib has a monoisotopic molecular weight of 586.32 Da. … Vevorisertib is under investigation in clinical trial NCT02761694 (Vevorisertib (ARQ 751) as a Single Agent or in Combination With Other Anti-Cancer Agents, in Solid Tumors With PIK3CA / AKT / PTEN Mutations

  7. Drug

    Amber

    go.drugbank.com/drugs/DB14326
    Investigational

    It is not an approved drug.

  8. Drug

    Mangostin

    go.drugbank.com/drugs/DB14371
    Investigational

    It is not an approved drug.

  9. Drug

    Pumice

    go.drugbank.com/drugs/DB14374
    Investigational

    It is not an approved drug.

  10. Drug

    Bevacizumab zirconium Zr-89

    go.drugbank.com/drugs/DB14907
    Investigational

    Bevacizumab zirconium Zr-89 is under investigation in clinical trial NCT01338090 (89Zr-bevacizumab PET Imaging in Patients With Neuroendocrine Tumors).